Literature DB >> 21161538

Long-term biochemical evaluation of the androgen receptor pathway in males with disorders of sex development.

C Schwentner1, J Czyz, J Seibold, T Todenhoefer, S H Alloussi, H Klocker, G Gakis, A Stenzl, M Baka-Ostrowska, C Radmayr.   

Abstract

PURPOSE: Disorders of sex (DSD) development represent a serious condition. Most of the underlying mechanisms remain unclear. Disturbances within the androgen receptor (AR) pathway frequently account for 46 XY-DSDs. The individual gender-related outcome often is unsatisfactory. We present a long-term AR gene-mutation-associated follow-up in a group of 46 XY-DSD patients.
METHODS: Twenty patients (46 XY) who underwent genitoplasty in infancy or early childhood were retrospectively identified. Median follow-up after surgery was 16 years. All were undervirilized at initial presentation. Thirteen had female gender assignment, and 7 were raised as males. A genital skin biopsy and subsequent fibroblast cultures were done. The specific binding of dihydrotestosterone, the thermostability of the receptor hormone complex, and 5-α-reductase activity were measured. AR gene mutations were detected by direct sequencing. The individual outcome was correlated with specific AR mutations.
RESULTS: AR point mutations were detected in 12, 7 were previously unknown. There was no specific androgen binding in 3, reduced affinity in 9, and normal binding in 8 patients. 5-α-Reductase activity was normal in 15, reduced in 4 and completely absent in 1 patient.
CONCLUSIONS: Retrospective evaluation revealed previously unknown and established AR gene mutations being associated with a distinct long-term outcome. Identification of the molecular mechanisms causing DSD will likely improve timely diagnosis and therapy. Exact characterization of AR activation and function may offer a treatment modality in affected patients. These data may allow us to give prognostic estimations on the individual outcome adding objective criteria for gender assignment in 46 XY-DSD patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21161538     DOI: 10.1007/s00345-010-0622-7

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  20 in total

1.  17Beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations.

Authors:  A L Boehmer; A O Brinkmann; L A Sandkuijl; D J Halley; M F Niermeijer; S Andersson; F H de Jong; H Kayserili; M A de Vroede; B J Otten; C W Rouwé; B B Mendonça; C Rodrigues; H H Bode; P E de Ruiter; H A Delemarre-van de Waal; S L Drop
Journal:  J Clin Endocrinol Metab       Date:  1999-12       Impact factor: 5.958

Review 2.  Androgen receptor defects: historical, clinical, and molecular perspectives.

Authors:  C A Quigley; A De Bellis; K B Marschke; M K el-Awady; E M Wilson; F S French
Journal:  Endocr Rev       Date:  1995-06       Impact factor: 19.871

3.  Phenotypic heterogeneity associated with identical mutations in residue 870 of the androgen receptor.

Authors:  Juan Carlos Zenteno; Bertha Chávez; Felipe Vilchis; Susana Kofman-Alfaro
Journal:  Horm Res       Date:  2002

4.  Hypospadias: a critical analysis of cosmetic outcomes using photography.

Authors:  L Baskin
Journal:  BJU Int       Date:  2001-04       Impact factor: 5.588

5.  Molecular features and clinical phenotypes in androgen insensitivity syndrome in the absence and presence of androgen receptor gene mutations.

Authors:  P M Holterhus; R Werner; U Hoppe; J Bassler; E Korsch; M B Ranke; H G Dörr; O Hiort
Journal:  J Mol Med (Berl)       Date:  2005-11-11       Impact factor: 4.599

6.  Cloning of human androgen receptor complementary DNA and localization to the X chromosome.

Authors:  D B Lubahn; D R Joseph; P M Sullivan; H F Willard; F S French; E M Wilson
Journal:  Science       Date:  1988-04-15       Impact factor: 47.728

7.  Novel (60%) and recurrent (40%) androgen receptor gene mutations in a series of 59 patients with a 46,XY disorder of sex development.

Authors:  L Audi; M Fernández-Cancio; A Carrascosa; P Andaluz; N Torán; C Piró; E Vilaró; E Vicens-Calvet; M Gussinyé; M A Albisu; D Yeste; M Clemente; I Hernández de la Calle; M Del Campo; T Vendrell; A Blanco; J Martínez-Mora; M L Granada; I Salinas; J Forn; J Calaf; O Angerri; M J Martínez-Sopena; J Del Valle; E García; R Gracia-Bouthelier; P Lapunzina; E Mayayo; J I Labarta; G Lledó; J Sánchez Del Pozo; J Arroyo; A Pérez-Aytes; M Beneyto; A Segura; V Borrás; E Gabau; M Caimarí; A Rodríguez; M J Martínez-Aedo; M Carrera; L Castaño; M Andrade; J A Bermúdez de la Vega
Journal:  J Clin Endocrinol Metab       Date:  2010-02-11       Impact factor: 5.958

8.  Complete androgen insensitivity syndrome is frequently due to premature stop codons in exon 1 of the androgen receptor gene: an international collaborative report of 13 new mutations.

Authors:  Pascal Philibert; Françoise Audran; Catherine Pienkowski; Isabelle Morange; Birgit Kohler; Elisabeth Flori; Claudine Heinrich; Catherine Dacou-Voutetakis; Marie-Geneviève Joseph; Anne-Marie Guedj; Hubert Journel; Annie-Claude Hecart-Bruna; Ines Khotchali; Svetlana Ten; Philippe Bouchard; Françoise Paris; Charles Sultan
Journal:  Fertil Steril       Date:  2009-05-21       Impact factor: 7.329

9.  Partial androgen insensitivity with phenotypic variation caused by androgen receptor mutations that disrupt activation function 2 and the NH(2)- and carboxyl-terminal interaction.

Authors:  Charmian A Quigley; Jiann-an Tan; Bin He; Zhong-xun Zhou; Farida Mebarki; Yves Morel; Maguelone G Forest; Pierre Chatelain; E Martin Ritzén; Frank S French; Elizabeth M Wilson
Journal:  Mech Ageing Dev       Date:  2004 Oct-Nov       Impact factor: 5.432

10.  Consensus statement on management of intersex disorders. International Consensus Conference on Intersex.

Authors:  Peter A Lee; Christopher P Houk; S Faisal Ahmed; Ieuan A Hughes
Journal:  Pediatrics       Date:  2006-08       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.